@Unibo & Brisighella Heart Study Group | SoMe Ambassador and Young Fellow of @society_eas | SoMe Editor of @ATHjournal
May 26 • 7 tweets • 3 min read
ApoB in 2026: the question is no longer whether ApoB matters. The question is how far ApoB can take us in understanding which particles drive risk (LDL, TRL/remnants, Lp(a)) and how we should act on them. #EASCongress2026 #MyEAS2026
One key message: LDL-C can be lowered to very low levels without apparent detriment. But ApoB reminds us that risk is not only about cholesterol mass. It is also about the number and biology of atherogenic particles. #EASCongress2026 #MyEAS2026